T45.AX3S Billable / specific Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, sequela

ICD-10-CM T45.AX3S identifies “Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, sequela” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 19: Injury, poisoning and certain other consequences of external causes

Exempt from present-on-admission reporting

Code-level instructions

No additional notes.

Inherited instructions

Chapters 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)

Excludes 22
  • birth trauma (P10-P15)
  • obstetric trauma (O70-O71)
Use additional code1

code to identify any retained foreign body, if applicable (Z18.-)

Note2
  • Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
  • The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.

T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)

Includes4
  • adverse effect of correct substance properly administered
  • poisoning by overdose of substance
  • poisoning by wrong substance given or taken in error
  • underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11

toxic reaction to local anesthesia in pregnancy (O29.3-)

Excludes 25
  • abuse and dependence of psychoactive substances (F10-F19)
  • abuse of non-dependence-producing substances (F55.-)
  • immunodeficiency due to drugs (D84.821)
  • drug reaction and poisoning affecting newborn (P00-P96)
  • pathological drug intoxication (inebriation) (F10-F19)
Code first7
  • , for adverse effects, the nature of the adverse effect, such as:
  • adverse effect NOS (T88.7)
  • aspirin gastritis (K29.-)
  • blood disorders (D56-D76)
  • contact dermatitis (L23-L25)
  • dermatitis due to substances taken internally (L27.-)
  • nephropathy (N14.0-N14.2)
Use additional code4
  • code(s) to specify:
  • manifestations of poisoning
  • underdosing or failure in dosage during medical and surgical care (Y63.6, Y63.8-Y63.9)
  • underdosing of medication regimen (Z91.12-, Z91.13-)
Note1

The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.

T45 · Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified

Seventh character1

The appropriate 7th character is to be added to each code from category T45

A — initial encounter

D — subsequent encounter

S — sequela

T45.A · Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs

Excludes 11

poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drug (T45.1)

Official index references

Official conversion history

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Release dates 2024-10-01

Previous assignment: T45.1X3S

History

Code history

Latest recorded change · FY2025 · 04-01

ChangedUnchanged
FY2025 · 04-01

Effective from

  • Inherited rules changed

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, sequela

Billable diagnosis code

CDC/NCHS · FY2025 · 04-01

All editions (5)

All editionsEffective fromCode history
FY20252024-10-01Added
FY2025 · 04-012025-04-01Inherited rules changed
FY20262025-10-01No tabular change
FY2026 · April2026-04-01No tabular change
FY20272026-10-01No tabular change

This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.